Searching the knowledge hub

Anaphylaxis kits are co-located in the vaccination room and in the post-vaccination area (which is the main part of the pharmacy) which ensures that those trained to administer adrenaline injections can access them quickly while minimising the impact on the COVID-19 vaccination service.

The pharmacy uses continual review processes to identify and manage risks associated with supplying medicines to people. It takes timely action to implement changes designed to reduce risk when supplying medicines.

GPhC engagement indicates that a good quality pharmacy-led COVID-19 vaccination site is one which has

• Clear leadership. The service has been well thought through with a clearly articulated written plan. The plan is person centred. It identifies and mitigates for the potential risks involved in providing the service. And everyone involved understands their roles and responsibilities.

• A well trained and well-motivated team. Team members are fully trained for their individual roles and have a good understanding of the service as a whole. The team regularly reviews the service so that it can modify it quickly to adapt to changing circumstances. And there is a culture of continuous improvement.

• A well-designed, well laid-out and well managed site. It has enough space for people to progress through the vaccination process in a logical fashion, while maintaining social distancing. And people do not unnecessarily cross paths with others. The site has regular robust cleaning routines and the patient journey is well thought through. People can find the site without difficulty, park easily and know what to expect when they get there. People are made welcome and are dealt with thoughtfully, efficiently and speedily throughout the service.

All members of the pharmacy team are vaccinated against COVID-19 and carry out twice weekly lateral flow tests. They continually risk assess their working practices and have identified that it is no longer necessary for the pharmacy to work in two separate groups and can now work as a whole team again. This means that the pharmacy has a more effective balance of workforce cover every day. And is helping the pharmacy team to get back to ‘normal’.

The pharmacy is using information from its engagement with COVID-19 Pharmacy-led vaccination sites to help it manage its services safely and effectively. It is taking swift action to help mitigate some concerns reported by these pharmacies. And it has put systems in place to manage the increased volume of telephone calls more easily.

The pharmacy is working closely with neighbouring pharmacies to ensure that, even if the pharmacy has to close temporarily, the supply of medicines to people will not be disrupted.

The pharmacy uses information from trustworthy sources to help keep its team members’ knowledge up to date during the pandemic. And to help ensure its approach to managing risk is consistent with both government and NHS guidance.

The pharmacy is considering the risks associated with the supply of medicines to vulnerable people during the pandemic. And it has implemented a system to help manage these risks should pharmacy team members be required to self-isolate during the COVID-19 pandemic.

The pharmacy is identifying and minimising the risks associated with making regular deliveries to care homes. And it is taking a number of steps to mitigate the risks identified. It is minimising the risk of spreading COVID-19 by adopting a series of hygiene measures for the team to follow.

The pharmacy uses individual team risk assessments to identify changes needed to the work environment to protect team members who are at greater risk of serious illness if they contract COVID-19.